Cargando…

The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma

Cells utilize different metabolic processes to maintain their growth and differentiation. Tumor cells have made some metabolic changes to protect themselves from malnutrition. These metabolic alterations affect the tumor microenvironment and macroenvironment. Developing drugs targeting these metabol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jianbo, Meng, Fuqing, Ran, Danyang, Song, Yalong, Dang, Yunkun, Lai, Fan, Yang, Longyan, Deng, Mi, Song, Yuqin, Zhu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300995/ https://www.ncbi.nlm.nih.gov/pubmed/37367892 http://dx.doi.org/10.3390/metabo13060734

Ejemplares similares

Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era
por: Nuersulitan, Reyizha, et al.
Publicado: (2022)

Treatment Strategies and Prognostic Factors of Primary Gastric Diffuse Large B Cell Lymphoma: A Retrospective Multicenter Study of 272 Cases from the China Lymphoma Patient Registry
por: Yang, Haiyan, et al.
Publicado: (2019)

Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma
por: He, Yizi, et al.
Publicado: (2019)

Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment
por: Zheng, Xiaohui, et al.
Publicado: (2014)

Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
por: Hu, Yunfei, et al.
Publicado: (2014)

BTK kinase activity is dispensable for the survival of diffuse large B-cell lymphoma
por: Yuan, Hongwei, et al.
Publicado: (2022)

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
por: Liu, Yalu, et al.
Publicado: (2017)

Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B-cell lymphoma
por: Ding, Huirong, et al.
Publicado: (2018)

A Comparison of Clinical Prognostic Indices in Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with a Pegylated Liposomal Doxorubicin Combination Regimen in China
por: Gao, Hongye, et al.
Publicado: (2022)

Diffuse large B-cell lymphoma: A metabolic disorder?
por: Tanios, Georges, et al.
Publicado: (2013)

Targetable Metabolic Vulnerability in Diffuse Large B-Cell Lymphoma
por: Xiong, Jie, et al.
Publicado: (2018)

Single nucleotide polymorphisms of CD20 gene and their relationship with clinical efficacy of R-CHOP in patients with diffuse large B cell lymphoma
por: Ding, Huirong, et al.
Publicado: (2013)

Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma
por: Fu, Zhiying, et al.
Publicado: (2014)

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma
por: Fan, Kenneth C., et al.
Publicado: (2019)

Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma
por: Yang, Haiyan, et al.
Publicado: (2022)

Risk Assessment in Diffuse Large B-Cell Lymphoma by Combining Baseline Metabolic Tumor Volume and Peking Criteria When Evaluating Series (18)F-Fluorodeoxyglucose Positron Emission Tomography Scans
por: Yuan, Tingting, et al.
Publicado: (2022)

Cerebrospinal Fluid Proteins Identification Facilitates the Differential Diagnosis of Central Nervous System Diffuse Large B Cell Lymphoma
por: Zheng, Wen, et al.
Publicado: (2017)

EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP
por: Li, Jiao, et al.
Publicado: (2017)

Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy
por: Li, Miaomiao, et al.
Publicado: (2022)

Expression of Tryptophan Metabolism Enzymes in Patients with Diffuse Large B‐cell Lymphoma and NK/T‐cell Lymphoma
por: Guo, Dan, et al.
Publicado: (2023)

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
por: Zhang, Wenqi, et al.
Publicado: (2021)

The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma
por: Wang, Xing, et al.
Publicado: (2021)

Diffuse large B cell lymphoma with high M protein: an unusual finding
por: Dang, Manavi, et al.
Publicado: (2015)

Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantation
por: Ying, Zhitao, et al.
Publicado: (2019)

Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma
por: Qin, Wei, et al.
Publicado: (2021)

Diffuse anterior retinoblastoma: current concepts
por: Yang, Jing, et al.
Publicado: (2015)

Homozygous A polymorphism of the complement C1qA(276) correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP
por: Jin, Xuan, et al.
Publicado: (2012)

A Case of B-cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-cell Lymphoma and Burkitt Lymphoma in a Korean Child
por: Ahn, Jeong Yeal, et al.
Publicado: (2012)

Primary diffuse large B-cell lymphoma in the maxilla: A case report
por: Zou, Haixiao, et al.
Publicado: (2018)

PB2375: PLTP REGULATES BCR SIGNALING AND TUMOR MICROENVIRONMENT IN DIFFUSE LARGE B-CELL LYMPHOMA THROUGH REPROGRAMMING OF LIPID METABOLISM ENVIRONMENT
por: Shi, Wenyu
Publicado: (2023)

Primary adrenal diffuse large B-cell lymphoma with normal adrenal cortex function: A case report
por: Fan, Zhi-Nan, et al.
Publicado: (2022)

Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphoma
por: Wang, Huizhong, et al.
Publicado: (2021)

The remodeling of metabolic brain pattern in patients with extracranial diffuse large B-cell lymphoma
por: Liu, Junyi, et al.
Publicado: (2023)

Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)

Treatment of Diffuse Large B Cell Lymphoma
por: Kwak, Jae-Yong
Publicado: (2012)

Lenalidomide in Diffuse Large B-Cell Lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2012)

Cutaneous diffuse large B‐cell lymphoma
por: Duarte Ribeiro, Filipa, et al.
Publicado: (2017)

Genomics of diffuse large B cell lymphoma
por: Koh, Youngil
Publicado: (2021)

Diffuse Large B-Cell Lymphoma of the Cecum
por: Azad, Farhan, et al.
Publicado: (2023)

Diffuse Large B-cell Lymphoma Arising from Chronic Tuberculous Empyema
por: Yun, Ju Sik, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ua2m3bc9bvaa5tk89pfcf2qnci